Strong, long lasting, T cell mediated protection against lethal heterosubtypic challenge can begenerated by intranasal priming with wild type or attenuated cold adapted strains of Influenza A virus. Bychallenging with virus of a different subtype we are able to focus on the role of memory T cells specific for theconserved core proteins of the influenza virus in the absence of preexisting antibody to the coat proteins of thechallenge virus.The T cell memory does not prevent infection of the lung epithelia following challenge but leads toenhanced numbers and earlier expansion of virus specific CD4 and CD8 T cells in the lung. We have shownthat there are marked changes in lung message for inflammatory cytokines and chemokines in the early part ofthe response and a later reduction in the recruitment of macrophages and neutrophils with the potential tomediate immunopathology. There is also an accelerated antibody response, an earlier clearance of the virus,less weight loss and 100% survival after challenge with a viral dose 100s of times greater than the lethal dose.Enhanced survival is abolished on removal of CD8 and is diminished upon removal of CD4 T cells.We believe that memory CD4 and CD8 T cells contribute in a number of ways to prevent the moredamaging effects of lethal viral challenge. This proposal aims to elucidate just how T cell memory protectsagainst lethal challenge and promotes survival and will test the following four hypotheses:1. The memory CD4 and CD8 T cells already resident in the lung make an early response toantigen that leads to an altered pattern of cytokine and chemokine secretion.2. It is the responses of memory T cells that bring about the key changes seen in primed mice.3. The early changes in the cytokine and chemokine expression seen in primed mice lead to thedownstream effects that contribute to the enhanced survival.4. Memory T cells can clear virus in the absence of neutralizing antibodies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI078298-01
Application #
7690550
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Ferguson, Stacy E
Project Start
2008-09-25
Project End
2009-08-31
Budget Start
2008-09-25
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$445,000
Indirect Cost
Name
Trudeau Institute, Inc.
Department
Type
DUNS #
020658969
City
Saranac Lake
State
NY
Country
United States
Zip Code
12983